Opioid-induced constipation (OIC) is treatable with a combination of lifestyle changes, over-the-counter laxatives, and, when those aren’t enough, prescription medications designed specifically for this problem. Unlike ordinary constipation, OIC is caused by opioids binding to receptors in your gut, which means standard remedies sometimes fall short and targeted treatments may be necessary.
Why Opioids Cause Constipation
Your intestines have their own network of opioid receptors. When you take an opioid pain medication, it doesn’t just act on your brain. It also binds to receptors lining your gut, and this triggers a chain of effects that slow everything down. The drugs reduce the release of key signaling chemicals from nerve endings in the intestinal wall, which inhibits the wave-like contractions that push stool through the colon. At the same time, opioids increase smooth muscle tone, making the intestinal walls stiffer and less able to move things along.
There’s a second problem happening simultaneously. Opioids suppress the nerve cells responsible for moving water and fluid into the colon. With less fluid in the intestinal space, stool becomes harder and drier, which makes it even more difficult to pass. This two-hit effect, slower movement plus drier stool, is why OIC can be so stubborn compared to other forms of constipation. And unlike many opioid side effects, your body generally does not build tolerance to this one. It persists for as long as you take the medication.
How to Recognize OIC
OIC is formally defined as new or worsening constipation that starts when you begin, increase, or change opioid therapy. To meet diagnostic criteria, you need at least two of the following symptoms occurring in more than 25% of your bowel movements: straining, lumpy or hard stools, a feeling of incomplete evacuation, a sensation of blockage, needing to use manual techniques to help pass stool, or having fewer than three spontaneous bowel movements per week. These symptoms should be present for at least two months.
In practice, most people don’t need a formal checklist to know something is wrong. If your bowel habits changed noticeably after starting or adjusting opioid medication, that’s almost certainly OIC.
Start With Lifestyle Adjustments
Before reaching for medication, basic lifestyle measures can provide some relief. Clinical guidelines recommend adequate fluid intake, regular physical activity, and a steady intake of dietary fiber. Soluble fiber (found in oats, beans, apples, and flaxseed) is generally more helpful than insoluble fiber for constipation. Fiber works by drawing water into the stool and increasing its bulk, which stimulates the colon to contract.
There’s an important caveat. Because opioids slow transit time through the colon, fiber may be less effective than it would be for ordinary constipation. Fiber also requires adequate hydration to work properly. Without enough water, adding fiber can actually make things worse. These measures are worth trying and are low-risk, but for many people on opioids, they won’t be sufficient on their own.
Over-the-Counter Laxatives
Laxatives are the preferred first-line treatment for OIC. The two main categories used are osmotic laxatives and stimulant laxatives, and they work through different mechanisms.
Osmotic laxatives pull water into the intestine, softening stool and making it easier to pass. Common options include polyethylene glycol (MiraLAX) and magnesium-based products like milk of magnesia. In large prescribing studies, osmotic laxatives are the most frequently used class for OIC, often started at the same time as the opioid itself.
Stimulant laxatives, such as bisacodyl (Dulcolax) and sennosides (Senokot), work by directly triggering contractions in the intestinal wall. They tend to produce results faster than osmotic agents but can cause cramping. Many clinicians recommend them as an addition when osmotic laxatives alone aren’t doing enough.
Stool softeners like docusate are widely used but have limited evidence for OIC specifically. They add moisture to stool but don’t address the underlying slowdown in gut motility. For mild cases they may help, but they’re generally the weakest option.
Prescription Options When Laxatives Fail
When over-the-counter laxatives don’t resolve OIC, prescription medications offer a more targeted approach. These fall into two main categories.
PAMORAs
The most important class of OIC-specific drugs is called PAMORAs (peripherally acting mu-opioid receptor antagonists). These medications block opioid receptors in the gut without crossing into the brain, so they relieve constipation without reducing pain control. Three are FDA-approved:
- Naloxegol (Movantik): an oral tablet approved for OIC in adults with chronic non-cancer pain.
- Naldemedine (Symproic): an oral tablet, also approved for chronic non-cancer pain.
- Methylnaltrexone (Relistor): available as both an oral tablet and a subcutaneous injection. It’s approved for chronic non-cancer pain and also for patients with advanced illness receiving palliative care who haven’t responded to laxatives.
PAMORAs can work quickly. In a clinical trial published in the New England Journal of Medicine, 48% of patients given methylnaltrexone had a bowel movement within four hours of the first dose, compared to 15% on placebo. Among those who responded within four hours, half had a response within 30 minutes. The median time to first bowel movement was about 6 hours with the drug versus more than 48 hours with placebo.
One important safety consideration: PAMORAs are not appropriate if you have a known or suspected bowel obstruction, or a history of one, because they can increase the risk of gastrointestinal perforation. Naldemedine’s labeling specifically notes the possibility of tears in the stomach or intestinal wall, though this is rare.
Chloride Channel Activators
Lubiprostone (Amitiza) takes a completely different approach. Instead of blocking opioid receptors, it activates chloride channels on the surface of intestinal cells, which increases fluid secretion into the gut. This directly counteracts one of the key problems in OIC: the opioid-driven reduction in intestinal fluid. The typical dose for OIC is 24 micrograms taken twice daily. Because it works on a different pathway than opioids use, it effectively bypasses the antisecretory effect of the drug rather than competing with it.
What a Typical Treatment Path Looks Like
In most cases, treatment follows a stepwise approach. Your provider will likely recommend starting an osmotic laxative, sometimes combined with a stimulant laxative, right when opioid therapy begins or as soon as constipation develops. If you’re still struggling after a reasonable trial (usually a couple of weeks), a PAMORA or lubiprostone becomes the next step.
Some people need ongoing combination therapy, using a daily osmotic laxative alongside a PAMORA, for example. Others find that a single targeted medication resolves the problem. The key point is that OIC is a predictable, physiological side effect of opioid therapy, not a failure of your diet or hydration habits. If basic measures aren’t working, that’s expected, and more effective options exist.
Practical Tips That Help
Timing matters. If you know you’re starting opioid therapy, beginning a laxative regimen from day one is more effective than waiting until constipation becomes severe. Once stool has been sitting in the colon for days, it becomes progressively harder and more difficult to move.
Stay consistent with whatever regimen you’re using. Osmotic laxatives work best when taken daily rather than as needed. Skipping doses and then doubling up tends to produce unpredictable results, alternating between no relief and urgent diarrhea.
Keep a simple log of your bowel movements, noting frequency and consistency. This gives you and your provider concrete information to guide treatment adjustments, rather than relying on general impressions that can be unreliable over weeks and months of opioid use.